Concepedia

Publication | Open Access

Phase II study of copanlisib, a PI3K inhibitor, in relapsed or refractory, indolent or aggressive lymphoma

DOIFull Paper Access

267

Citations

17

References

2017

Year

M. Dreyling, Franck Morschhauser, Krimo Bouabdallah, Dominique Bron, David Cunningham, Sarit Assouline, G. Verhoef, Kim Linton, Catherine Thiéblemont, Umberto Vitolo,
Annals of Oncology

References

YearCitations

Page 1